BANGKOK (AP) — World shares started out the week mixed after U.S. stocks fell to their worst loss since Election Day.
U.S. futures were also mixed, with the S&P 500 contract up less than 0.1% and that for the Dow Jones Industrial Average 0.1% lower as speculation mounted over who President-elect Donald Trump might nominate to be his Treasury secretary.
Germany's DAX lost 0.2% to 19,178.02, while the CAC 40 edged 0.1% lower to 7,259.95. Britain's FTSE 100 gained 0.2% 8,079.04.
In Asian trading, Japan's Nikkei 225 index dropped 1.1% to 38,220.85 as the yen initially regained some strength against the U.S. dollar after the central bank governor, Kazuo Ueda, indicated that the Bank of Japan will continue to raise interest rates as conditions permit.
The dollar inched up to 154.76 Japanese yen from 154.54 yen late Friday. It had been trading above 156 yen last week.
South Korea's Kospi jumped 2.2% to 2,469.07 after Samsung Electronics, the country's biggest company, announced a share buyback plan. Samsung's shares jumped 6%.
Chinese markets were mixed. The Hang Seng in Hong Kong added 0.8% to 19,576.61, while the Shanghai Composite index shed early gains to close down 0.2% at 3,323.55.
Elsewhere in Asia, Australia's S&P/ASX 200 edged 0.2% higher, to 8,300.20. Taiwan's Taiex lost 0.9% and the SET in Bangkok picked up 0.7% as the government announced that Thailand's economy grew more than expected in the last quarter.
On Friday, U.S. stocks tumbled Friday with the waning of the “Trump bump” that Wall Street got from last week’s presidential election, along with a cut to interest rates by the Federal Reserve.
The S&P 500 dropped 1.3% for its worst day since before Election Day. The Dow slumped 0.7% and the Nasdaq composite sank 2.2%.
Vaccine manufacturers helped drag the market down after President-elect Donald Trump said he wants Robert F. Kennedy Jr., a prominent anti-vaccine activist, to lead the Department of Health and Human Services. Moderna tumbled 7.3%, and Pfizer fell 4.7% amid concerns about a possible hit to profits.
Kennedy still needs confirmation from the Senate to get the job, and some analysts are skeptical about his chances.
Stocks had been broadly roaring since Election Day, when Trump’s victory sent a jolt through financial markets worldwide. Investors immediately began sending up stocks of banks, smaller U.S. companies and cryptocurrencies as they laid bets on the winners coming out of Trump’s preference for higher tariffs, lower tax rates and lighter regulation.
But investors are also taking into account some of the potential downsides from Trump’s return to the White House, including worries that his policies could spur bigger U.S. government deficits and faster inflation.
A report Friday showed shoppers spent more at U.S. retailers last month than expected, suggesting consumer spending, the most influential force on the economy, remains solid.
In other dealings early Monday, U.S. benchmark crude oil added 37 cents to $67.39 per barrel in electronic trading on the New York Mercantile Exchange. Brent crude climbed 49 cents to $71.52 per barrel.
The euro bought $1.0539, up from $1.0534 late Friday.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.